HEBE Project - Healthy Aging Versus Inflamm-aging: the Role of Physical Exercise in Modulating the Biomarkers of Age-associated and Environmentally Determined Chronic Diseases
HEBE
HEBE - Healthy Aging Versus Inflamm-aging: the Role of Physical Exercise in Modulating the Biomarkers of Age-associated and Environmentally Determined Chronic Diseases. Research Line 1. Proof of Concept
1 other identifier
interventional
100
1 country
1
Brief Summary
The main objective of this clinical trial is to test the effects of the personalized intervention based on physical exercise, on clinical variables and circulating markers, in a population of employees of the University of Milan (UMilan). The HEBE study will include two phases: PHASE 1: All UMilan employees will be asked to voluntarily complete an anonymous online questionnaire, in order to gather information about their lifestyle (physical activity, diet, cigarette smoking, etc) (zero time: T0); at the end of the compilation, indications on how to improve the lifestyle will be provided. These indications will also be present and available for consultation in a special section of the site on the "HEBE" site, with UMilan domain (www.hebe.unimi.it). After 6 months, all UMilan employees will receive a second invitation to voluntarily complete the same questionnaire, in order to evaluate any changes, in terms of lifestyle improvement (time one: T1). PHASE 2: 100 eligible subjects who have expressed their availability in the initial questionnaire, will be identified to undergo a lifestyle improvement protocol based mainly on the prescription of a personalized exercise program, which will define modalities, intensity, duration, frequency and progression of the exercise. For each subject, at T0 and T1 (after 6 months), biological samples will be collected (blood, urine, saliva and nasal swab), which will be used to: i) set up a biobank shared by the members of the HEBE consortium; ii) identify biomarkers able to monitor the effect of physical exercise on the characteristics of the frailty under examination. Furthermore, both at T0 and T1 questionnaires will be completed and carried out clinical evaluations (anamnesis, physical examination, tests for the study of the autonomic nervous system, bio-impedance test, evaluation/estimate of maximal oxygen consumption, ECG).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 22, 2023
CompletedFirst Submitted
Initial submission to the registry
March 1, 2023
CompletedFirst Posted
Study publicly available on registry
April 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2023
CompletedApril 18, 2023
April 1, 2023
4 months
March 1, 2023
April 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in maximal oxygen consumption (VO2 max)
The maximum or optimum rate at which the heart, lungs, and muscles can effectively use oxygen during exercise, used as a way of measuring a person's individual aerobic capacity.
Change from baseline VO2 max at six months
Study Arms (1)
Physical exercise prescription
EXPERIMENTALPrescription of a personalized exercise program, which will define modalities, intensity, duration, frequency and progression of the exercise. For each subject, at baseline and after 6 months, biological samples will be collected (blood, urine, saliva and nasal swab)
Interventions
Personalized exercise program, with defined modalities, intensity, duration, frequency and progression of the exercise.
Eligibility Criteria
You may qualify if:
- Being an employee of UMilan of both sexes and of any age (18-70 years);
- For the 100 chosen subjects identified for Phase 2: declare that they do not carry out physical activities at a competitive level and that you are committed about improving your own lifestyle.
You may not qualify if:
- Previous myocardial infarction
- Autoimmune diseases
- Neurodegenerative pathologies
- Psychiatric pathologies
- Cardiac arrhythmias
- Chronic obstructive pulmonary disease
- osteo-muscular problems that prevent the execution of physical activity;
- oncological pathologies in the last 3 years that have required chemotherapy or immunotherapy;
- pregnancy/nursing/intention to become pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Milanlead
- Istituto Auxologico Italianocollaborator
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinicocollaborator
Study Sites (1)
University of Milan
Milan, 20122, Italy
Related Publications (1)
Bianchi F, Biganzoli EM, Bollati V, Clerici M, Lucini D, Mando C, Rota F; HEBE Consortium. HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol. PLoS One. 2024 Apr 30;19(4):e0300011. doi: 10.1371/journal.pone.0300011. eCollection 2024.
PMID: 38687742DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Elia M Biganzoli, PhD
University of Milan
- PRINCIPAL INVESTIGATOR
Daniela Lucini, PhD
University of Milan
- PRINCIPAL INVESTIGATOR
Valentina Bollati, PhD
University of Milan
- PRINCIPAL INVESTIGATOR
Francesca Bianchi, PhD
University of Milan
- PRINCIPAL INVESTIGATOR
Chiara Mandò, PhD
University of Milan
- STUDY CHAIR
Mario Clerici, PhD
University of Milan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor of Medical Statistics
Study Record Dates
First Submitted
March 1, 2023
First Posted
April 18, 2023
Study Start
November 8, 2022
Primary Completion
February 22, 2023
Study Completion
July 20, 2023
Last Updated
April 18, 2023
Record last verified: 2023-04